Document is current
Any future updates will be listed below
-
Authors
Vennier, Alice
Canet, Emmanuel https://orcid.org/0000-0002-2143-8082
Guardiolle, Vianney
Reizine, Florian
Trochu, Jean-Noël
Le Tourneau, Thierry
Touzeau, Cyrille
Houot, Roch
Seguin, Amélie
Reignier, Jean
Lascarrou, Jean-Baptiste
Tadié, Jean-Marc
Emarié, Jérémie https://orcid.org/0000-0002-4121-9186
- License Information
-
More Information
Article History
Received: 25 December 2022
Accepted: 13 July 2023
First Online: 18 July 2023
Declarations
:
: This study was approved by the ethics committee of the French Intensive Care Society (CE SRLF 22-058) on December 18, 2022.
: In accordance with French law on retrospective studies of anonymized healthcare data, informed consent was not required.
: EC has received lecturer and conference-speaker fees, as well as reimbursements of travel and accommodation expenses related to attending scientific meetings, from Gilead, Shionogi, and Sanofi-Genzyme. JBL has received lecturer and conference-speaker fees from BD and Zoll. RH reports honoraria from Kite/Gilead, Novartis, Incyte, Janssen, MSD, Takeda and Roche; and consultancy at Kite/Gilead, Novartis, Bristol-Myers Squibb/Celgene, ADC Therapeutics, Incyte, Miltenyi. None of the other authors have relevant financial or non-financial interests to disclose.
